Ticker
ORMPCompany Name
ORAMED PHARMACEUTICALS INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQDate | Revenues | Stock Based Compensation | Stock Based Compensation Margin |
---|---|---|---|
6/30/2025 | $ 2M | $ 4.52M | 225.95% |
3/31/2025 | $ 2M | $ 4.95M | 247.4% |
12/31/2024 | $ 0 | $ 4.05M | 0% |
9/30/2024 | $ 0 | $ 4.19M | 0% |
6/30/2024 | $ 0 | $ 4.74M | 0% |
3/31/2024 | $ 674K | $ 5.33M | 791.25% |
12/31/2023 | $ 1.34M | $ 4.21M | 314.33% |
9/30/2023 | $ 2.02M | $ 5.39M | 266.85% |
6/30/2023 | $ 2.7M | $ 7.59M | 280.84% |
3/31/2023 | $ 2.7M | $ 7.65M | 283.13% |
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
SB Comp. / Revenues
(=) SB Comp %
SB Comp % for ORAMED PHARMACEUTICALS INC is calculated as follows: SB Comp. [ $ 1.17M ] / Revenues [ $ 2.71M ]
(=) SB Comp % [ 43.28% ]
Minimum
Sep 30, 2020
Maximum
Mar 31, 2024
Average
Median
filtered constituents | 2.98K |
---|---|
min | -3.97% |
max | 8.43% |
average | 1.72% |
median | 1.04% |
std | 1.9% |